Background The COVID-19 pandemic was a disaster that had far reaching effects on healthcare services, one of which being sexual and reproductive health. By disrupting the majority of in-person healthcare services, as well as the function of many supply chains, people across the globe faced difficulties in accessing the goods and services they relied on. This review is attempting to answer the question, what were the impacts of the COVID-19 pandemic on women’s access to contraceptives? Methods Web of Science was searched on February 26, 2025 for studies reporting on participants’ ability to access contraceptives during the COVID-19 pandemic, compared to before and/or after. Studies must have been conducted exclusively in people who identify as women, and who were engaged with contraceptives at the start of the pandemic. Data were narratively synthesized and grouped based on changes in use of contraceptives attributed to pandemic, and unintended pregnancies. Results This review includes 7 included studies which represent 9 countries and 84,562 people. Women’s ages range from 12-50 years. Study size ranges from about 200 to over 70,000. Available data suggests that the COVID-19 pandemic had deleterious effects on reproductive health. Fear of becoming infected prevented many women from accessing contraceptives as they were able to pre-pandemic. COVID-19 related economic losses have also been linked to changes in fertility intentions, in turn changing contraceptives and family planning for some women. There was a reduction in dispensing of pharmaceutical contraceptives, such as the hormonal pill. There was an increase in unintended pregnancies. However, widespread use of long-acting reversible contraceptives (LARCs) eliminated some risks that arise from disruptions in services. Conclusion The current structure of the health care delivery system does not support equitable access to contraceptives. COVID-19 is one of many factors that can exacerbate this. Globally, interventions to address gaps in sexual education have the potential to improve access to and knowledge of contraception; this may be particularly critical during disruptions such as COVID-19 which can impact supply chains and access to healthcare providers.